Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.65% | -0.17% | +0.68% | +0.61% | +0.37% |
| Weighted Average Shares Diluted Growth | +0.65% | -0.17% | +0.68% | +0.61% | +0.37% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -20.56% | -21.12% | -21.84% | -22.64% | -21.27% |
| Book Value per Share Growth | -21.85% | -21.93% | -23.55% | -24.76% | -25.07% |
| Debt Growth | -11.98% | -12.73% | -13.55% | -14.46% | -1.51% |
| R&D Expense Growth | -8.92% | -10.82% | -16.66% | -22.03% | +0.69% |
| SG&A Expenses Growth | -57.25% | -19.13% | -23.95% | -18.22% | +110.47% |